Related Experiment Video
Updated: Aug 8, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with
Xin-Zi Chi1, Jeung-Ook Yang, Kwang-Youl Lee
1Department of Biochemistry, School of Medicine, and Institute for Tumor Research, Chungbuk National University, Cheongju 361-763, South Korea.
Abstract:
RUNX3 has been suggested to be a tumor suppressor of gastric cancer. The gastric mucosa of the Runx3-null mouse develops hyperplasia due to enhanced proliferation and suppressed apoptosis accompanied by a decreased sensitivity to transforming growth factor beta1 (TGF-beta1). It is known that TGF-beta1 induces cell growth arrest by activating CDKN1A (p21(WAF1)(/Cip1)), which encodes a cyclin-dependent kinase inhibitor, and this signaling cascade is considered to be a tumor suppressor pathway. However, the lineage-specific transcription factor that cooperates with SMADs to induce p21 expression is not known. Here we show that RUNX3 is required for the TGF-beta-dependent induction of p21 expression in stomach epithelial cells. Overexpression of RUNX3 potentiates TGF-beta-dependent endogenous p21 induction. In cooperation with SMADs, RUNX3 synergistically activates the p21 promoter. In contrast, RUNX3-R122C, a mutation identified in a gastric cancer patient, abolished the ability to activate the p21 promoter or cooperate with SMADs. Furthermore, areas in mouse and human gastric epithelium where RUNX3 is expressed coincided with those where p21 is expressed. Our results suggest that at least part of the tumor suppressor activity of RUNX3 is associated with its ability to induce p21 expression.
Insights
RUNX3 acts as a tumor suppressor in gastric cancer by inducing p21 expression. This transcription factor cooperates with SMADs to activate the p21 promoter, crucial for cell growth arrest.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- RUNX3 is implicated as a tumor suppressor in gastric cancer.
- RUNX3 deficiency leads to gastric hyperplasia, increased proliferation, and reduced apoptosis.
- Transforming growth factor beta1 (TGF-beta1) pathway, involving p21(WAF1/Cip1) induction, is a known tumor suppressor pathway.
Purpose of the Study:
- To identify the lineage-specific transcription factor cooperating with SMADs to induce p21 expression.
- To elucidate the role of RUNX3 in TGF-beta1-mediated p21 induction in gastric epithelial cells.
Main Methods:
- Analysis of Runx3-null mouse gastric mucosa.
- Overexpression studies of RUNX3.
- Reporter assays to assess p21 promoter activity.
- Co-expression analysis of RUNX3 and p21 in mouse and human gastric epithelium.
Main Results:
- RUNX3 is essential for TGF-beta-dependent p21 expression in stomach cells.
- RUNX3 overexpression enhances endogenous p21 induction.
- RUNX3 and SMADs synergistically activate the p21 promoter.
- A patient-derived RUNX3 mutation (R122C) impairs p21 promoter activation.
- RUNX3 and p21 expression patterns overlap in gastric epithelium.
Conclusions:
- RUNX3 is a key regulator of TGF-beta-induced p21 expression in gastric epithelial cells.
- RUNX3's tumor suppressor function is partly mediated by its ability to induce p21.
- RUNX3 acts in concert with SMADs to suppress gastric tumor development.
Related Concept Videos
Negative Regulator Molecules
Canonical Wnt Signaling Pathway
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

